Trade TELO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Telomir Pharmaceuticals, Inc. (TELO) is trading at US$1.23, up 9.82% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$77.72M. Over the past 52 weeks, TELO has traded between US$0.89 and US$2.09. On Syfe you can trade TELO with $0 commission and add it to your watchlist.
| Previous close | US$1.12 |
|---|---|
| Market cap | US$77.72M |
| 52-week range | US$0.89 – US$2.09 |
| Volume | 475.61K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Miami, FL.
Year: 2024
Telomir Names Andriy Mushak as Fractional Chief Financial Officer
Jun 9, 12:07 PM · MT Newswires
Telomir Says US FDA Clears Investigational New Drug Application for Telomir-Zn to Treat Triple-Negative Breast Cancer
Apr 30, 2:26 PM · MT Newswires
Telomir Pharmaceuticals, Inc. (TELO) stock is trading at US$1.23, +9.82% from the previous close of US$1.12.
The market cap for Telomir Pharmaceuticals, Inc. (TELO) stock is approximately US$77.72M.
The 52-week high for Telomir Pharmaceuticals, Inc. (TELO) stock is US$2.09.
The 52-week low for Telomir Pharmaceuticals, Inc. (TELO) stock is US$0.89.
Telomir Pharmaceuticals, Inc. (TELO) does not currently pay a dividend.
Stay on top of TELO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
